Related references
Note: Only part of the references are listed.The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
A. D. Hartkopf et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
Francois-Clement Bidard et al.
CANCER AND METASTASIS REVIEWS (2013)
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients
Brigitte Rack et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer
Malgorzata Banys et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
Bahriye Aktas et al.
GYNECOLOGIC ONCOLOGY (2011)
Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients
Sven Becker et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Tanja Fehm et al.
BREAST CANCER RESEARCH (2009)
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
Helga Bernhard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Tanja Fehm et al.
BREAST CANCER RESEARCH (2008)
Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients
Sven Becker et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients
Erich F. Solomayer et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment
Silke Lankiewicz et al.
MOLECULAR BIOTECHNOLOGY (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells
T Fehm et al.
CYTOTHERAPY (2005)
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
W Janni et al.
CANCER (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Image analysis systems for the detection of disseminated breast cancer cells on bone-marrow cytospins
S Becker et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells
N Reimers et al.
CLINICAL CANCER RESEARCH (2004)
Circulating breast cancer cells are frequently apoptotic
G Méhes et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells
F Tögel et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer:: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques
BM Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
S Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
